Vasee Moorthy

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

Samuel McConkey, William H. H. Reece, Vasee Moorthy et al. · Nature Medicine · 2003 · 557 citations · Full text

Vaccination, Vaccine Development, Immunology +8

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser et al. · New England Journal of Medicine · 2015 · 404 citations · Full text

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

Angela Huttner, Julie-Anne Dayer, Sabine Yerly et al. · The Lancet Infectious Diseases · 2015 · 276 citations

Vaccination, Vaccine Safety, Vaccinology +9

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

Milagritos D. Tapia, Samba O. Sow, Kirsten E. Lyke et al. · The Lancet Infectious Diseases · 2015 · 213 citations · Full text

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015

Kayvon Modjarrad, Birgitte Giersing, David C. Kaslow et al. · Vaccine · 2015 · 202 citations · Full text

Respiratory Virus Immunity, Respiratory Complications, Vaccine Hesitancy +16